Product Overview
SS‑31 (Elamipretide): Targeted Mitochondrial Energy & Cellular Protection
Why SS‑31 is of special interest: Mitochondrial decline contributes to fatigue, muscle weakness, and age‑related energy loss. By supporting mitochondrial function at the source, SS‑31 may promote sustained vitality, exercise tolerance, and resilience in energy‑demanding tissues such as the heart, muscle, and brain.
Potential Benefits Shown in Early Limited Evaluations
Early research (pre‑clinical and small human studies) has explored:
-
Improved mitochondrial respiration and reduced oxidative stress in aging or diseased cells
-
Better physical performance and cardiac function in animal stress models
-
Promising safety and subtle energy/metabolic improvements in early human mitochondrial disorder trials
Note: SS‑31 has been discussed in stacks with other peptides. These combinations may potentially provide enhanced results depending on the research indication. Findings remain limited and require further human studies for safety and efficacy. Human clinical data remains limited, and SS‑31 is not FDA‑approved for therapeutic use; it is primarily researched or used off‑label/investigationally.
What SS‑31 Is
SS‑31 is a tetrapeptide—four amino acids long—with the sequence D‑Arg‑Dmt‑Lys‑Phe‑NH₂. It is a synthetic mitochondria‑targeting peptide designed to mimic and enhance the body’s natural mechanisms for protecting mitochondrial function during stress or aging.
How It Works (Mechanism of Action)
SS‑31 selectively binds cardiolipin in the inner mitochondrial membrane. This stabilizes the electron transport chain, reduces harmful reactive oxygen species, and restores efficient ATP production—without affecting other cellular systems.
Backed by Science
-
Pre‑clinical studies in isolated mitochondria and animal models of heart failure and neurodegeneration showed SS‑31 restores electron transport efficiency, boosts ATP production, and protects against oxidative damage
-
Early‑phase clinical data in patients with primary mitochondrial myopathy confirmed SS‑31 is well‑tolerated and improves functional measures
Disclaimer
Peptides are sold for laboratory research use only. They are not for human, medical, or veterinary use. Buyers must be qualified to handle research materials and assume full responsibility for their safe use.